Results 21 to 30 of about 22,017 (188)

Quetiapine misuse and abuse: Is it an atypical paradigm of drug seeking behavior?

Journal of Research in Pharmacy Practice, 2017
Recent case reports in medical literatures suggest that more and more second-generation atypical antipsychotics (AAs) have been prescribed for off-label use; quetiapine (Brand name: Seroquel®) showed increase in its trend for off-label use.
Sean Kim, Gayoung Lee, Eric Kim, Hyejin Jung, Jongwha Chang   +4 more
doaj   +1 more source

Inappropriate quetiapine use at a large academic medical center: frequency of misuse and associated costs of adverse effects

Therapeutic Advances in Drug Safety, 2023
Background: Quetiapine is an antipsychotic with dose-related receptor affinity, which is commonly prescribed by specialties outside of psychiatry. Quetiapine can have adverse effects including weight gain, hyperglycemia, and falls.
Winter Roth, David Dadiomov, Michelle Chu   +2 more
doaj   +1 more source

Acute toxicity of ADB‐CHMINACA ‐ a case series of patients with pronounced central nervous symptoms including the posterior reversible encephalopathic syndrome

British Journal of Clinical Pharmacology, EarlyView.
Aim This report presents a series of 16 patients who were admitted to the emergency department following confirmed intake of the potent synthetic cannabinoid ADB‐CHMINACA. Methods The cases are drawn from a prospective observational study following the recreational use of synthetic cannabinoids.
Maren Hermanns‐Clausen, Michaela Sommer, Annette Zschiesche, Verena Angerer, Martin Scheu, Florian Eyer, Johannes Nadler, Volker Auwärter   +7 more
wiley   +1 more source

Comparison of Quetiapine Abuse and Misuse Reports to the FDA Adverse Event Reporting System With Other Second-Generation Antipsychotics

Substance Abuse: Research and Treatment, 2019
Background: Second-generation antipsychotics (SGAs) are assumed to have little abuse potential. However, reports of quetiapine abuse have emerged as prescribing has increased in recent years.
Kirk E Evoy, Chengwen Teng, Victor G Encarnacion, Brian Frescas, John Hakim, Stephen Saklad, Christopher R Frei   +6 more
doaj   +1 more source

Lurasidone versus Quetiapine for Cognitive Impairments in Young Patients with Bipolar Depression: A Randomized, Controlled Study

Pharmaceuticals, 2022
The clinical efficacy of lurasidone and quetiapine, two commonly prescribed atypical antipsychotics for bipolar depression, has been inadequately studied in young patients. In this randomized and controlled study, we aimed to compare the effects of these
Xiangyuan Diao, Dan Luo, Dandan Wang, Jianbo Lai, Qunxiao Li, Peifen Zhang, Huimin Huang, Lingling Wu, Shaojia Lu, Shaohua Hu   +9 more
doaj   +1 more source

Psychotropic medication use among community dwellers with and without Parkinson's disease – A nationwide cohort study

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims We studied the prevalence of psychotropic use and psychotropic polypharmacy in persons with Parkinson's disease (PD) during a 10‐year follow‐up, because longitudinal studies on this topic are scarce although non‐motor symptoms of PD are often treated with psychotropics.
Noora Nieminen, Anna‐Maija Tolppanen, Valtteri Kaasinen, Marjaana Koponen, Sirpa Hartikainen   +4 more
wiley   +1 more source

Electrocardiographic changes and clinical outcomes in quetiapine poisoning: a retrospective cohort study

Toxicology Communications
Introduction Quetiapine has a three-ringed chemical structure similar to that of tricyclic antidepressants (TCA). Several electrocardiogram (ECG) findings, including prolonged QRS intervals, high R wave amplitude (tall RaVR), large R-wave/S-wave ratio ...
Fumiya Inoue, Takuyo Chiba, Yuji Okazaki, Toshihisa Ichiba, Akira Namera, Sachiko Ohde   +5 more
doaj   +1 more source

Intensive Care Management of a Case of Cardiac Arrest Following Ketiapine Use

Türk Yoğun Bakim Derneği Dergisi, 2012
Quetiapine is an antipsychotic commonly used in treatment of depression, bipolar disorders and schizophrenia. Quetiapine interacts with several receptors present in the central nervous system and therefore may cause diverse side effects like somnolence ...
Ahmet Şen, Yakup Tomak, Başar Erdivanlı, Aysel Kurt   +3 more
doaj   +1 more source

Increasing the reporting of adverse drug reaction‐related hospitalizations using an ICD‐10‐based identification workflow: A multicentre study from Switzerland

British Journal of Clinical Pharmacology, EarlyView.
Background Reporting adverse drug reactions (ADRs) is essential for drug safety. In Switzerland, healthcare professionals are legally required to report serious and unlabelled ADRs, yet under‐reporting remains widespread. We tested a novel method to increase reporting of ADR‐related hospitalizations.
Georgia Anita Weber, Sophie‐Charlotte Bartel, Michael Boch, Christoph Rosen, Michael Bodmer, Balthasar Luzius Hug, Thomas Stammschulte, Patrick E. Beeler   +7 more
wiley   +1 more source

A prospective series of acute rivaroxaban overdose, coagulopathy and bleeding complications (ATOM 11)

British Journal of Clinical Pharmacology, EarlyView.
Aim There is limited research describing rivaroxaban overdose. We aim to describe rivaroxaban overdose, coagulopathy and bleeding complications. Methods This is a prospective series of acute adult (>14 years) rivaroxaban overdose presentations >40 mg enrolled in the Australian Toxicology Monitoring study and presenting to three Australian clinical ...
Katherine Z. Isoardi, Angela L. Chiew, Keith Harris, Geoffrey K. Isbister   +3 more
wiley   +1 more source